Datasets:
drug stringlengths 1 97 | disease stringlengths 1 157 ⌀ | label stringclasses 2
values | explanation stringlengths 5 1.03k |
|---|---|---|---|
GF-BETA | Diabetic Foot Ulcers | effective | GF-BETA, also known as Becaplermin, is a topical gel formulation of recombinant human platelet-derived growth factor (PDGF). It has been shown to be effective in treating diabetic foot ulcers and other chronic wounds by promoting wound healing through the stimulation of cell proliferation and angiogenesis. Clinical tri... |
GF-BETA | Venous Leg Ulcers | effective | GF-BETA, also known as Becaplermin, is a topical gel formulation of recombinant human platelet-derived growth factor (PDGF). It has been shown to be effective in treating diabetic foot ulcers and other chronic wounds by promoting wound healing through the stimulation of cell proliferation and angiogenesis. Clinical tri... |
GF-BETA | Pressure Ulcers | effective | GF-BETA, also known as Becaplermin, is a topical gel formulation of recombinant human platelet-derived growth factor (PDGF). It has been shown to be effective in treating diabetic foot ulcers and other chronic wounds by promoting wound healing through the stimulation of cell proliferation and angiogenesis. Clinical tri... |
GF-BETA | Cancer | ineffective | GF-BETA, also known as Becaplermin, is a topical gel formulation of recombinant human platelet-derived growth factor (PDGF). It has been shown to be effective in treating diabetic foot ulcers and other chronic wounds by promoting wound healing through the stimulation of cell proliferation and angiogenesis. Clinical tri... |
GF-BETA | Cardiovascular Diseases | ineffective | GF-BETA, also known as Becaplermin, is a topical gel formulation of recombinant human platelet-derived growth factor (PDGF). It has been shown to be effective in treating diabetic foot ulcers and other chronic wounds by promoting wound healing through the stimulation of cell proliferation and angiogenesis. Clinical tri... |
DP (DIHYDROARTEMISININ-PIPERAQUINE) | Malaria | effective | DP (Dihydroartemisinin-Piperazine) is a combination drug that has shown high efficacy in treating malaria due to its potent antimalarial activity. Dihydroartemisinin rapidly kills the parasites, while piperquine provides a longer-lasting effect, reducing the risk of recurrence. Clinical trials have demonstrated signifi... |
DP (DIHYDROARTEMISININ-PIPERAQUINE) | particularly Plasmodium falciparum and Plasmodium vivax | effective | DP (Dihydroartemisinin-Piperazine) is a combination drug that has shown high efficacy in treating malaria due to its potent antimalarial activity. Dihydroartemisinin rapidly kills the parasites, while piperquine provides a longer-lasting effect, reducing the risk of recurrence. Clinical trials have demonstrated signifi... |
DP (DIHYDROARTEMISININ-PIPERAQUINE) | Cancer | ineffective | DP (Dihydroartemisinin-Piperazine) is a combination drug that has shown high efficacy in treating malaria due to its potent antimalarial activity. Dihydroartemisinin rapidly kills the parasites, while piperquine provides a longer-lasting effect, reducing the risk of recurrence. Clinical trials have demonstrated signifi... |
DP (DIHYDROARTEMISININ-PIPERAQUINE) | Neurodegenerative diseases | ineffective | DP (Dihydroartemisinin-Piperazine) is a combination drug that has shown high efficacy in treating malaria due to its potent antimalarial activity. Dihydroartemisinin rapidly kills the parasites, while piperquine provides a longer-lasting effect, reducing the risk of recurrence. Clinical trials have demonstrated signifi... |
DP (DIHYDROARTEMISININ-PIPERAQUINE) | Bacterial infections | ineffective | DP (Dihydroartemisinin-Piperazine) is a combination drug that has shown high efficacy in treating malaria due to its potent antimalarial activity. Dihydroartemisinin rapidly kills the parasites, while piperquine provides a longer-lasting effect, reducing the risk of recurrence. Clinical trials have demonstrated signifi... |
DOCOSAHEXAENOIC ACID (DHA) | Hypertriglyceridemia | effective | Docosahexaenoic acid (DHA) is an omega-3 fatty acid that has been shown to effectively treat hypertriglyceridemia by reducing triglyceride levels in the blood. It also plays a crucial role in infant brain development, particularly in the formation of the brain and retina. However, its efficacy in treating Alzheimer's d... |
DOCOSAHEXAENOIC ACID (DHA) | Infant Brain Development Disorders | effective | Docosahexaenoic acid (DHA) is an omega-3 fatty acid that has been shown to effectively treat hypertriglyceridemia by reducing triglyceride levels in the blood. It also plays a crucial role in infant brain development, particularly in the formation of the brain and retina. However, its efficacy in treating Alzheimer's d... |
DOCOSAHEXAENOIC ACID (DHA) | Alzheimer's Disease | ineffective | Docosahexaenoic acid (DHA) is an omega-3 fatty acid that has been shown to effectively treat hypertriglyceridemia by reducing triglyceride levels in the blood. It also plays a crucial role in infant brain development, particularly in the formation of the brain and retina. However, its efficacy in treating Alzheimer's d... |
DOCOSAHEXAENOIC ACID (DHA) | Type 2 Diabetes | ineffective | Docosahexaenoic acid (DHA) is an omega-3 fatty acid that has been shown to effectively treat hypertriglyceridemia by reducing triglyceride levels in the blood. It also plays a crucial role in infant brain development, particularly in the formation of the brain and retina. However, its efficacy in treating Alzheimer's d... |
ELTANEXOR | Hematological malignancies | effective | Eltanexor is a second-generation selective inhibitor of nuclear export (SINE) compound that targets the XPO1 pathway. Clinical and preclinical data have shown promising results in treating hematological malignancies like AML and MDS due to its ability to inhibit the nuclear export of tumor suppressor proteins, leading ... |
ELTANEXOR | such as Acute Myeloid Leukemia (AML) | effective | Eltanexor is a second-generation selective inhibitor of nuclear export (SINE) compound that targets the XPO1 pathway. Clinical and preclinical data have shown promising results in treating hematological malignancies like AML and MDS due to its ability to inhibit the nuclear export of tumor suppressor proteins, leading ... |
ELTANEXOR | Myelodysplastic Syndromes (MDS) | effective | Eltanexor is a second-generation selective inhibitor of nuclear export (SINE) compound that targets the XPO1 pathway. Clinical and preclinical data have shown promising results in treating hematological malignancies like AML and MDS due to its ability to inhibit the nuclear export of tumor suppressor proteins, leading ... |
ELTANEXOR | Solid tumors | ineffective | Eltanexor is a second-generation selective inhibitor of nuclear export (SINE) compound that targets the XPO1 pathway. Clinical and preclinical data have shown promising results in treating hematological malignancies like AML and MDS due to its ability to inhibit the nuclear export of tumor suppressor proteins, leading ... |
ELTANEXOR | Non-hematological cancers | ineffective | Eltanexor is a second-generation selective inhibitor of nuclear export (SINE) compound that targets the XPO1 pathway. Clinical and preclinical data have shown promising results in treating hematological malignancies like AML and MDS due to its ability to inhibit the nuclear export of tumor suppressor proteins, leading ... |
STREPTOMYCIN (STR) | Tuberculosis (TB) | effective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
STREPTOMYCIN (STR) | Plague | effective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
STREPTOMYCIN (STR) | Brucellosis | effective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
STREPTOMYCIN (STR) | Urinary Tract Infections (UTIs) | ineffective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
STREPTOMYCIN (STR) | Pneumococcal infections | ineffective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
STREPTOMYCIN (STR) | Anaerobic bacterial infections | ineffective | Streptomycin is an aminoglycoside antibiotic that effectively treats TB, plague, and brucellosis by inhibiting protein synthesis in bacteria. Clinical trials and preclinical data have demonstrated its efficacy against these diseases, with significant therapeutic outcomes. However, its use in treating UTIs, pneumococcal... |
DIMETHYL-CELECOXIB (DMC) | Familial Adenomatous Polyposis (FAP) | effective | Dimethyl-celecoxib (DMC) is a derivative of celecoxib, and it has shown effectiveness in treating FAP and colorectal cancer due to its potent inhibition of cyclooxygenase-2 (COX-2), which plays a crucial role in tumor growth and progression. Preclinical studies have demonstrated that DMC can reduce polyp formation and ... |
DIMETHYL-CELECOXIB (DMC) | Colorectal Cancer | effective | Dimethyl-celecoxib (DMC) is a derivative of celecoxib, and it has shown effectiveness in treating FAP and colorectal cancer due to its potent inhibition of cyclooxygenase-2 (COX-2), which plays a crucial role in tumor growth and progression. Preclinical studies have demonstrated that DMC can reduce polyp formation and ... |
DIMETHYL-CELECOXIB (DMC) | Rheumatoid Arthritis | ineffective | Dimethyl-celecoxib (DMC) is a derivative of celecoxib, and it has shown effectiveness in treating FAP and colorectal cancer due to its potent inhibition of cyclooxygenase-2 (COX-2), which plays a crucial role in tumor growth and progression. Preclinical studies have demonstrated that DMC can reduce polyp formation and ... |
DIMETHYL-CELECOXIB (DMC) | Alzheimer's Disease | ineffective | Dimethyl-celecoxib (DMC) is a derivative of celecoxib, and it has shown effectiveness in treating FAP and colorectal cancer due to its potent inhibition of cyclooxygenase-2 (COX-2), which plays a crucial role in tumor growth and progression. Preclinical studies have demonstrated that DMC can reduce polyp formation and ... |
CHLOROQUINE (CQ) | Malaria | effective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
CHLOROQUINE (CQ) | Rheumatoid Arthritis | effective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
CHLOROQUINE (CQ) | Lupus | effective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
CHLOROQUINE (CQ) | COVID-19 | ineffective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
CHLOROQUINE (CQ) | Cancer | ineffective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
CHLOROQUINE (CQ) | Bacterial Infections | ineffective | Chloroquine (CQ) has been shown to be effective against malaria due to its ability to interfere with the parasite's heme detoxification pathway. It also exhibits immunomodulatory effects, making it useful in treating rheumatoid arthritis and lupus. However, its efficacy in treating COVID-19 is unclear and controversial... |
SHENLING BAIZHU POWDER (SBP) | Diarrhea-predominant irritable bowel syndrome (IBS-D) | effective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
SHENLING BAIZHU POWDER (SBP) | Chronic diarrhea | effective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
SHENLING BAIZHU POWDER (SBP) | Gastrointestinal disorders | effective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
SHENLING BAIZHU POWDER (SBP) | Inflammatory bowel disease (IBD) | ineffective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
SHENLING BAIZHU POWDER (SBP) | Cancer | ineffective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
SHENLING BAIZHU POWDER (SBP) | Diabetes | ineffective | Shenling Baizhu Powder (SBP) is a traditional Chinese medicine that has been shown to be effective in treating gastrointestinal disorders such as IBS-D and chronic diarrhea. Clinical studies have demonstrated its ability to regulate gut motility, improve intestinal barrier function, and modulate the gut microbiome. How... |
CEFEPIME/AVIBACTAM | Complicated Urinary Tract Infections (cUTI) | effective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
CEFEPIME/AVIBACTAM | Complicated Intra-Abdominal Infections (cIAI) | effective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
CEFEPIME/AVIBACTAM | Hospital-Acquired Bacterial Pneumonia (HABP) | effective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
CEFEPIME/AVIBACTAM | Ventilator-Associated Bacterial Pneumonia (VABP) | effective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
CEFEPIME/AVIBACTAM | Bacterial Meningitis | ineffective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
CEFEPIME/AVIBACTAM | Orthopedic Infections | ineffective | Cefepime/Avibactam is a combination antibiotic that has shown strong efficacy against a range of Gram-negative bacteria, including those producing beta-lactamase enzymes. Clinical trials have demonstrated its effectiveness in treating cUTI, cIAI, HABP, and VABP, with significant improvement in patient outcomes. The avi... |
FANSIMEF | Not Applicable - No known diseases | effective | There is no information available on a drug named FANSIMEF, suggesting it may not be a real or recognized pharmaceutical agent. As a result, there are no clinical or preclinical data to assess its effectiveness for any disease, and its interaction with target genes or pathways is unknown. Without evidence of therapeuti... |
FANSIMEF | All diseases - No clinical data available | ineffective | There is no information available on a drug named FANSIMEF, suggesting it may not be a real or recognized pharmaceutical agent. As a result, there are no clinical or preclinical data to assess its effectiveness for any disease, and its interaction with target genes or pathways is unknown. Without evidence of therapeuti... |
ZIPALERTINIB | Non-Small Cell Lung Cancer (NSCLC) | effective | Zipalertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which has shown efficacy in treating NSCLC, particularly in patients with EGFR mutations. Clinical trials have demonstrated significant improvement in progression-free survival and overall response rates in this patien... |
ZIPALERTINIB | Breast Cancer | ineffective | Zipalertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which has shown efficacy in treating NSCLC, particularly in patients with EGFR mutations. Clinical trials have demonstrated significant improvement in progression-free survival and overall response rates in this patien... |
ZIPALERTINIB | Colorectal Cancer | ineffective | Zipalertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which has shown efficacy in treating NSCLC, particularly in patients with EGFR mutations. Clinical trials have demonstrated significant improvement in progression-free survival and overall response rates in this patien... |
DIURETIC | Hypertension | effective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
DIURETIC | Edema | effective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
DIURETIC | Heart Failure | effective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
DIURETIC | Nephrotic Syndrome | effective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
DIURETIC | Diabetes Insipidus | ineffective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
DIURETIC | Hypercalcemia | ineffective | Diuretics are effective in treating hypertension, edema, heart failure, and nephrotic syndrome by increasing urine production, reducing fluid overload, and lowering blood pressure. Clinical trials have demonstrated significant therapeutic outcomes in these conditions due to the drug's ability to interact with renal ion... |
ACV | Herpes Simplex Virus (HSV) infections | effective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
ACV | Varicella-Zoster Virus (VZV) infections | effective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
ACV | Herpes Zoster (shingles) | effective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
ACV | HIV | ineffective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
ACV | Influenza | ineffective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
ACV | Common Cold | ineffective | The drug ACV (Acyclovir) is effective against HSV and VZV infections due to its selective inhibition of viral DNA synthesis. Clinical trials have shown significant reduction in symptoms and improvement in patient outcomes for these diseases. However, its efficacy in treating HIV, influenza, and common cold is unclear o... |
GEPOTIDACIN | Community-Acquired Bacterial Pneumonia (CABP) | effective | Gepotidacin has shown effectiveness against CABP and ABSSSI due to its mechanism as a novel, oral, dual-inhibitor of bacterial DNA gyrase and topoisomerase IV. Clinical trials indicate significant therapeutic outcomes in treating these infections. However, the efficacy of gepotidacin for cUTIs and HABP is less clear, r... |
GEPOTIDACIN | Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | effective | Gepotidacin has shown effectiveness against CABP and ABSSSI due to its mechanism as a novel, oral, dual-inhibitor of bacterial DNA gyrase and topoisomerase IV. Clinical trials indicate significant therapeutic outcomes in treating these infections. However, the efficacy of gepotidacin for cUTIs and HABP is less clear, r... |
GEPOTIDACIN | Complicated Urinary Tract Infections (cUTIs) | ineffective | Gepotidacin has shown effectiveness against CABP and ABSSSI due to its mechanism as a novel, oral, dual-inhibitor of bacterial DNA gyrase and topoisomerase IV. Clinical trials indicate significant therapeutic outcomes in treating these infections. However, the efficacy of gepotidacin for cUTIs and HABP is less clear, r... |
GEPOTIDACIN | Hospital-Acquired Bacterial Pneumonia (HABP) | ineffective | Gepotidacin has shown effectiveness against CABP and ABSSSI due to its mechanism as a novel, oral, dual-inhibitor of bacterial DNA gyrase and topoisomerase IV. Clinical trials indicate significant therapeutic outcomes in treating these infections. However, the efficacy of gepotidacin for cUTIs and HABP is less clear, r... |
CRANBERRY JUICE | Urinary Tract Infections (UTIs) | effective | Cranberry juice has been shown to be effective in preventing and treating UTIs due to its ability to prevent bacterial adhesion to the bladder and urinary tract walls. Proanthocyanidins, compounds found in cranberries, have been identified as the key components responsible for this effect. However, the evidence for its... |
CRANBERRY JUICE | Kidney Stones | ineffective | Cranberry juice has been shown to be effective in preventing and treating UTIs due to its ability to prevent bacterial adhesion to the bladder and urinary tract walls. Proanthocyanidins, compounds found in cranberries, have been identified as the key components responsible for this effect. However, the evidence for its... |
CRANBERRY JUICE | Cancer | ineffective | Cranberry juice has been shown to be effective in preventing and treating UTIs due to its ability to prevent bacterial adhesion to the bladder and urinary tract walls. Proanthocyanidins, compounds found in cranberries, have been identified as the key components responsible for this effect. However, the evidence for its... |
CRANBERRY JUICE | Cardiovascular Disease | ineffective | Cranberry juice has been shown to be effective in preventing and treating UTIs due to its ability to prevent bacterial adhesion to the bladder and urinary tract walls. Proanthocyanidins, compounds found in cranberries, have been identified as the key components responsible for this effect. However, the evidence for its... |
WR99120 | African Trypanosomiasis | effective | WR99120 has shown promise in treating African Trypanosomiasis due to its ability to interact with the trypanosome's kinetoplast DNA, disrupting the parasite's energy metabolism. Preclinical studies have demonstrated its potency against this disease. However, its efficacy against other parasitic diseases such as malaria... |
WR99120 | Malaria | ineffective | WR99120 has shown promise in treating African Trypanosomiasis due to its ability to interact with the trypanosome's kinetoplast DNA, disrupting the parasite's energy metabolism. Preclinical studies have demonstrated its potency against this disease. However, its efficacy against other parasitic diseases such as malaria... |
WR99120 | Chagas disease | ineffective | WR99120 has shown promise in treating African Trypanosomiasis due to its ability to interact with the trypanosome's kinetoplast DNA, disrupting the parasite's energy metabolism. Preclinical studies have demonstrated its potency against this disease. However, its efficacy against other parasitic diseases such as malaria... |
WR99120 | Leishmaniasis | ineffective | WR99120 has shown promise in treating African Trypanosomiasis due to its ability to interact with the trypanosome's kinetoplast DNA, disrupting the parasite's energy metabolism. Preclinical studies have demonstrated its potency against this disease. However, its efficacy against other parasitic diseases such as malaria... |
JANUS GREEN | Cancer (specifically | effective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
JANUS GREEN | targeted therapy for certain types of leukemia and lymphoma) | effective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
JANUS GREEN | Parasitic infections (such as malaria and toxoplasmosis) | effective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
JANUS GREEN | Bacterial infections | ineffective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
JANUS GREEN | Viral infections (like HIV and influenza) | ineffective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
JANUS GREEN | Neurodegenerative diseases | ineffective | Janus Green is a dye that has been found to have potential therapeutic effects due to its ability to interact with mitochondria and induce apoptosis in cancer cells. Preclinical studies have shown promising results in targeting certain types of leukemia and lymphoma, as well as parasitic infections like malaria. Howeve... |
MITOXANTRONE (MITOX) | Multiple Sclerosis (MS) | effective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | Acute Myeloid Leukemia (AML) | effective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | Prostate Cancer | effective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | Solid tumors such as breast cancer | ineffective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | lung cancer | ineffective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | and colon cancer | ineffective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
MITOXANTRONE (MITOX) | HIV-associated dementia | ineffective | Mitoxantrone is effective in treating MS by reducing the frequency of relapses due to its immunomodulatory effects. It also shows efficacy in AML and prostate cancer by intercalating DNA and inhibiting topoisomerase II, leading to apoptosis of cancer cells. Clinical trials have demonstrated significant therapeutic outc... |
STIBOGLUCONATE | Cutaneous Leishmaniasis | effective | Stibogluconate is an antimonial compound that has been shown to be effective in treating cutaneous leishmaniasis due to its ability to inhibit the enzyme trypanothione reductase, which is essential for the parasite's survival. Clinical trials have demonstrated significant therapeutic outcomes in patients with cutaneous... |
STIBOGLUCONATE | Visceral Leishmaniasis | ineffective | Stibogluconate is an antimonial compound that has been shown to be effective in treating cutaneous leishmaniasis due to its ability to inhibit the enzyme trypanothione reductase, which is essential for the parasite's survival. Clinical trials have demonstrated significant therapeutic outcomes in patients with cutaneous... |
STIBOGLUCONATE | Mucocutaneous Leishmaniasis | ineffective | Stibogluconate is an antimonial compound that has been shown to be effective in treating cutaneous leishmaniasis due to its ability to inhibit the enzyme trypanothione reductase, which is essential for the parasite's survival. Clinical trials have demonstrated significant therapeutic outcomes in patients with cutaneous... |
SOF | Hepatitis C (genotypes 1-6) | effective | The drug Sofosbuvir (SOF) is effective against hepatitis C due to its mechanism of action as a nucleotide analog inhibitor of the NS5B polymerase, which plays a crucial role in the replication of the hepatitis C virus. Clinical trials have demonstrated high sustained virological response rates in patients with chronic ... |
SOF | Chronic Hepatitis C | effective | The drug Sofosbuvir (SOF) is effective against hepatitis C due to its mechanism of action as a nucleotide analog inhibitor of the NS5B polymerase, which plays a crucial role in the replication of the hepatitis C virus. Clinical trials have demonstrated high sustained virological response rates in patients with chronic ... |
TEMOZOLOMIDE | Glioblastoma multiforme (GBM) | effective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
TEMOZOLOMIDE | Anaplastic astrocytoma | effective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
TEMOZOLOMIDE | Metastatic melanoma | effective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
TEMOZOLOMIDE | Recurrent ovarian cancer | ineffective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
TEMOZOLOMIDE | Advanced renal cell carcinoma | ineffective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
TEMOZOLOMIDE | Pancreatic cancer | ineffective | Temozolomide is effective against GBM and anaplastic astrocytoma due to its ability to cross the blood-brain barrier and alkylate DNA, leading to tumor cell death. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients with these brain tumors. Additiona... |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 14